AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3
slide-4
slide-5

Vidglit-M Tablet PR

Prescription Icon
Prescription Required

Marketer

Dios Lifesciences Pvt Ltd

Salt Composition

Metformin (500mg) + Teneligliptin (20mg)

Overview Vidglit-M Tablet PR

Duo-Control Diabetes Tablets are a dual-action medication managing elevated blood glucose in type 2 diabetes patients. This helps avert serious diabetic complications like renal impairment and vision loss, potentially lowering heart attack and stroke risk. Duo-Control Tablets may be used independently or in conjunction with other diabetic therapies. Optimal efficacy requires adherence to a healthy diet and regular physical activity. Dosage is individualized based on your health status, blood sugar readings, and current medications. Consuming it with meals minimizes stomach upset. Consistent daily dosing at the same time maximizes benefits; discontinuation should only occur under medical supervision. Effective blood sugar control prevents future complications. Maintaining your prescribed diet and exercise regimen is crucial. Lifestyle choices significantly impact diabetes management. Common side effects include nausea, vomiting, diarrhea, stomach discomfort, and headache. Hypoglycemia is a potential side effect, especially when combined with insulin or sulfonylureas; learn its symptoms and management. This medication isn't suitable for all. Inform your physician of any prior kidney, liver, or heart conditions, pancreatic issues, or significant alcohol consumption before starting. Pregnant or lactating individuals require medical consultation. Interactions with other drugs are possible; disclose all medications to your doctor. Alcohol should be limited due to its hypoglycemic effect. Your doctor will monitor kidney function and blood sugar levels throughout treatment.

Uses of Vidglit-M Tablet PR

Managing type 2 diabetes

Major Benefits of Vidglit-M Tablet PR:

Follow your doctor's instructions or consult the product label for usage guidance. Administer Vidglit-M Tablet PR with a meal.

Common Side effects of Vidglit-M Tablet PR:

  • Nausea
  • Vomiting
  • Headache
  • Hypoglycemia (low blood glucose level)
  • Diarrhea

How to use Vidglit-M Tablet PR:

Follow your physician's instructions or consult the product information leaflet for dosage guidance. Administer Vidglit-M Tablet PR with a meal.

How Vidglit-M Tablet PR works:

The prescription medication Vidglit-M Tablet combines two distinct antidiabetic agents.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Avoid alcohol while taking Vidglit-M Tablet PR.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Vidglit-M Tablet PR during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Use of Vidglit-M Tablet PR while breastfeeding is likely inadvisable. Available human data indicate a potential for the medication to transfer to breast milk, posing a risk to the infant.

DrivingDrivingCONSULT YOUR DOCTOR

The effect of Vidglit-M Tablet PR on driving ability is undetermined. Refrain from driving if you experience symptoms impairing concentration or reaction time.

KidneyKidneyCAUTION

Exercise caution when administering Vidglit-M Tablet PR to individuals with impaired kidney function; dosage modification may be necessary. Consult your physician for guidance. Vidglit-M Tablet PR is contraindicated in patients exhibiting severe renal insufficiency. Routine monitoring of renal parameters is recommended during treatment.

LiverLiverUNSAFE

Patients with liver impairment should likely refrain from using Vidglit-M Tablet PR, as it poses a potential risk. A physician's consultation is recommended.

What if you forget to take Vidglit-M Tablet PR :

Should you forget a Vidglit-M Tablet PR dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Vidglit-M Tablet PR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Vidglit-M Tablet PR

Vidglit-M Tablet PR is safe when used as directed by your doctor. However, even with correct dosage, side effects such as nausea, diarrhea, vomiting, stomach upset, headache, nasal congestion, sore throat, respiratory infection, and hypoglycemia (low blood sugar) may occur. Hypoglycemia is more likely if you're also taking insulin or sulfonylurea. Report any persistent side effects to your doctor.
Vidglit-M Tablet PR typically doesn't cause low blood sugar (hypoglycemia) by itself. However, hypoglycemia can result from insufficient caloric intake while using this medication. Symptoms such as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, and shakiness may occur. These symptoms are more pronounced if meals are missed or delayed, alcohol is consumed, excessive exercise is undertaken, or other antidiabetic medications are used concurrently. Therefore, regular blood sugar monitoring is crucial. Always keep glucose tablets, honey, or fruit juice readily available.
Nausea and vomiting are possible side effects of Vidglit-M Tablet PR. If vomiting occurs, sip small amounts of water or other fluids frequently. Consult your doctor if vomiting continues or you experience dehydration symptoms such as dark, strong-smelling urine and infrequent urination. Do not take other medications without your doctor's approval.
Vidglit-M Tablet PR is contraindicated in patients with allergies to its components or excipients. It should also be avoided in those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Vidglit-M Tablet PR can cause lactic acidosis (MALA, or Metformin-associated lactic acidosis), a rare but serious side effect resulting from excessive blood lactic acid. This risk is higher in patients with kidney disease, older adults, and heavy alcohol users. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If experienced, discontinue Vidglit-M Tablet PR and seek immediate medical attention.
Prolonged Vidglit-M Tablet PR use can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency may result in anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and balance problems), urinary issues, and cognitive changes. Consult your physician if you experience these symptoms; they may recommend vitamin B12 level monitoring and supplementation.
Store this medication in its original, tightly closed container, as directed on the label. Discard any unused medication safely and ensure it's inaccessible to children, pets, and others.
Vidglit-M Tablet PR
121
MRP 140
13% off